Abstract

Several Schiff base ligands derived from tris(hydroxymethyl)aminomethane were synthesized and a series of diorganotin(IV) complexes were obtained from the reaction of diorganotin dichlorides or oxides with Schiff base ligands. The ligands and complexes have been characterized by elemental analysis, IR, 1H, 13C and 119Sn NMR spectroscopies. Single-crystal X-ray diffraction analysis reveals that bis[(2-{[1,1-bis(hydroxymethyl)-2-oxidoethyl]iminomethyl}phenolato)]dimethyltin(IV), 1 and bis[(2-{[1,1-bis(hydroxymethyl)-2-oxidoethyl]iminomethyl}-4-bromophenolato)]dimethyltin(IV), 7 are dimeric structures, in which the central tin atom is rendered six-coordinate while (2-{[1,1-bis(hydroxymethyl)-2-oxidoethyl]iminomethyl}-4-bromophenolato)diphenyltin(IV), 9, (2-{[1,1-bis(hydroxymethyl)-2-oxidoethyl]iminomethyl}-4-chlorophenolato)dimethyltin(IV), 13, (2-{[1,1-bis(hydroxymethyl)-2-oxidoethyl]iminomethyl}-4-chlorophenolato)diphenyltin(IV), 15 and (2-{[1,1-bis(hydroxymethyl)-2-oxidoethyl]iminomethyl}-4-chlorophenolato)dicyclohexyltin(IV), 16 are monomeric structures, whereby the tin atom is in a distorted trigonal–bipyramidal configuration. The Schiff bases and their corresponding diorganotin(IV) complexes have been evaluated against three human carcinoma cell lines, namely HT29 (human colon carcinoma cell line), SKOV-3 (human ovarian cancer cell line) and MCF-7 (hormone-dependent breast carcinoma cell line), for its in vitro cytotoxic activities. The dibutyltin and dicyclohexyltin derivatives of the Schiff base ligands display good cytotoxic activities against the tested cell lines.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.